Cancer
Cancer Ongoing 2021 North Shore NSW

CA017-078

A study to evaluate nivolumab + chemotherapy or nivolumab/ BMS-986205 + chemotherapy followed by continued Immuno-Oncology therapy after radical cystectomy (RC).

Trial overview

Disease
CA017-078
Topic
CA017-078
Description
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.
Further info

For eligibility criteria and  further information regarding this clinical trial click here.

Location

North Shore NSW